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Menopause is associated with increased risk to develop obesity but the mechanisms
involved are not fully understood. We have shown that Ginkgo biloba extract (GbE)
improved diet-induced obesity. Since GbE might be effective in the treatment of
obesity related to menopause, avoiding the side effects of hormone replacement
therapy, we investigated the effect of GbE on hypothalamic systems controlling energy
homeostasis. Wistar rats were either ovariectomized (OVX) or Sham-operated. After
2 months, either 500 mg.kg−1 of GbE or vehicle were administered daily by gavage
for 14 days. A subset of animals received an intracerebroventricular (i.c.v.) injection
of serotonin (300 µg) or vehicle and food intake was measured after 12 and 24 h.
Another subset was submitted to in vivo microdialysis and 5-HT levels of the medial
hypothalamus were measured by high performance liquid chromatography, before and
up to 2 h after the administration of 500 mg.kg−1 of GbE. Additional animals were
used for quantification of 5-HT1A, 5-HT1B, 5-HT2C, 5-HTT, and pro-opiomelanocortin
hypothalamic protein levels by Western blotting. OVX increased food intake and body
weight and adiposity while GbE attenuated these alterations. i.c.v. serotonin significantly
reduced food intake in Sham, Sham + GbE, and OVX + GbE groups while it failed
to do so in the OVX group. In the OVX rats, GbE stimulated 5-HT microdialysate
levels while it reduced hypothalamic 5-HTT protein levels. The results indicate that
GbE improved the ovariectomy-induced resistance to serotonin hypophagia, at least in
part through stimulation of the hypothalamic serotonergic activity. Since body weight
gain is one of the most important consequences of menopause, the stimulation of
the serotonergic transmission by GbE may represent a potential alternative therapy for
menopause-related obesity.
Keywords: ovariectomy, obesity, serotonin, hypothalamus, food intake, in vivo microdialysis, Ginkgo biloba
extract
Abbreviations: 5-HIAA, 5-hydroxyindoleacetic acid; 5-HT1A, serotonin receptor 1A; 5-HT1B, serotonin receptor 1B;
5-HT2C, serotonin receptor 2C; 5-HTT, serotonin transporter; α-MSH, α-melanocyte-stimulating hormone; AgRP, agouti-
related protein; AP, anteroposterior (stereotaxic coordinate); CART, cocaine- and amphetamine-regulated transcript; DV,
dorsoventral (stereotaxic coordinate); ER, estrogen receptor; GbE, Ginkgo biloba (standardized) extract; GbE 761, Ginkgo
biloba 761 standardized extract; HRT, hormone replacement therapy; kcal, kilocalorie; ML, mediolateral (stereotaxic
coordinate); NPY, neuropeptide Y; OVX, ovariectomized; POMC, pro-opiomelanocortin; Sham, false-ovariectomized; T◦C,
temperature in Celsius degrees; U, units.
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INTRODUCTION
Menopause is a physiological condition characterized by the loss
of ovarian function (Dalal and Agarwal, 2015). Hypoestrogenism
has been identified as the main factor of menopause-associated
alterations, which include obesity, decreased energy expenditure,
vasomotor symptoms, insomnia, and psychological disturbances,
all affecting negatively the quality of life (Al-Safi and Santoro,
2014; Jenabi et al., 2015).
Estrogens are known to play an important role in the
homeostatic control of food intake and body weight (Eckel, 2011;
Asarian and Geary, 2013). During the estrous phase, female
rats exhibited a decrease in the size of spontaneous meals, a
pattern similar to that observed in women, which presented
daily food intake alterations during the hormonal fluctuations
of the ovarian cycle. On the other hand, estradiol replacement
attenuated ovariectomy-induced binge eating and high body
weight in rats (Yu et al., 2011; Baker and Runfola, 2016).
A role of estrogens as modulators of the central serotonergic
activity has been demonstrated, but with both stimulatory and
inhibitory effects on the system. Indeed, they reportedly increased
the expression of tryptophan hydroxylase and of serotonergic
receptors and auto-receptors (Bethea et al., 2002, 2016; Hiroi and
Neumaier, 2009; Barth et al., 2015).
Central serotonin (5-HT) plays a pivotal role in the control
of energy homeostasis due to its anorexigenic action, exerted
mainly via the receptor subtypes 5-HT1B and 5-HT2C (Huang
et al., 2004). Moreover, increased 5-HT availability, as evoked by
5-HT reuptake inhibitors, induces hypophagia in both humans
and animals (Huang et al., 2004; Olivier and van Oorschot, 2005).
However, studies about the central activity of 5-HT in a situation
of lack of ovarian hormones are very scarce.
Ginkgo biloba is one of the herbal medicines most used
worldwide (Diamond and Bailey, 2013). G. biloba 761
standardized extract (GbE 761), made from its dried green
leaves, is one of the best extracts related to therapeutic purposes.
It has been described that G. biloba has beneficial effects on
neurological disturbances, including memory loss, dementia,
mood fluctuations, psychomotor symptoms, and psychiatric
disorders such as schizophrenia and Alzheimer’s disease
(Diamond and Bailey, 2013; Montes et al., 2015). We have
recently demonstrated that GbE administration to diet-induced
obese rats led to significant decrements of food intake, body
weight gain and visceral adiposity, suggesting its potential as a
weight management therapy (Banin et al., 2014; Hirata et al.,
2015).
There are few studies examining the effect of GbE on
serotonergic pathways. In a review about its neuroprotective
effects, GbE has been reported to prevent the aging-induced
reductions in 5-HT levels and 5-HT1A receptors density in the
rat cerebral cortex. Furthermore, GbE 761 stimulated 5-HT
uptake by cortical synaptosomes of mice, an action attributed to
its flavonoid component quercetin (Ahlemeyer and Krieglstein,
2003). GbE 761 has recently been shown to inhibit reuptake
transporters of norepinephrine, serotonin, and dopamine, as
well as to decrease monoamine oxidase (MAO) activity (Fehske
et al., 2009). Interestingly, the use of GbE and other herbal
medicines, as alternative or complementary therapy, by post-
menopausal women has been shown improve mood, hot flashes,
and cognitive symptoms (Kam et al., 2002; Clement et al., 2011).
However, there is no data about beneficial effects of GbE on
the control of food intake and body weight gain related to
menopause.
The present study aimed at investigating, in an ovariectomized
(OVX) rat model, whether the lack of ovarian hormones affects
aspects of the central serotonergic system related to energy
balance and whether GbE therapy is able to modify these
effects.
MATERIALS AND METHODS
Animals and Ovariectomy Surgery
All procedures were approved by the Ethics Committee on
Animal Research of the Universidade Federal de São Paulo
(process number: CEP 0024/13), which follows the guidelines
of National Institutes of Health guide for the care and use
of Laboratory animals (NIH Publications No. 8023, revised
1978). Throughout the experimental period, the female Wistar
rats were maintained under controlled temperature (23 ± 1◦C)
and lighting conditions (lights on from 6 a.m. to 6 p.m.),
with free access to water and balanced diet (Nuvilab R©, Brazil,
2.79 kcal.g−1).
OVX (n = 49) or Sham (n = 48) were performed by the
dorsal approach in 2-month-old female rats anesthetized with
ketamine/xylazine (66.6/13.3 mg.kg−1, i.p.) and treated with an
oral dose (25 mg.kg−1 body weight) of ibuprofen. After the
surgery, a subcutaneous dose of 300,000 U.kg−1 body weight
of penicillin (1,200,000U benzathine benzylpenicillin Bepeben R©)
was administered. An analgesic reinforcement was carried out 12,
24, and 36 h after the surgery. In all animals, ovariectomy was
confirmed at the end of the experimental period, by the atrophy
of the uteri, contrasting with the false-OVX animals.
Both body weight and daily food intake were measured once
weekly for 8 weeks since the surgeries and then the phytotherapy
treatment was initiated. Food efficiency was calculated by the
ratio of body weight gain (g)/food ingestion (g) (de Sá et al., 2016)
during the 8-week period after ovariectomy.
Phytotherapy Treatment
GbE was obtained from Huacheng Biotech Inc. (China). The
composition of GbE included flavone glycosides (25.21%),
terpenoids (6.62%), ginkgolides A, B, C (3.09%), and bilobalides
(2.73%).
Two months after ovariectomy, the Sham and OVX rats
were randomly divided into four groups, treated with either
vehicle or GbE: Sham (n = 24), Sham + GbE (n = 24), OVX
(n = 24), and OVX + GbE (n = 25). The treatment consisted of
a gavage with 500 mg.kg−1 GbE diluted in 1.5 mL 0.9% saline
(groups Sham + GbE and OVX + GbE) or 1.5 mL of vehicle
(groups Sham and OVX) and was performed once daily for 14
days. During the treatment, body weight and food intake were
measured daily and cumulative food intake was calculated as the
sum of the daily dietary intakes of the whole treatment period.
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FIGURE 1 | Timeline of the experimental design.
A schematic timeline of major events involving the experimental
groups is shown in Figure 1.
Stereotaxic Surgery
At the 7th day of phytotherapy treatment, the rats were
anesthetized with ketamine/xylazine (66.6/13.3 mg.kg−1; i.p.)
and, after the administration of an oral dose (25 mg.kg−1 of body
weight) of ibuprofen, they were submitted to stereotaxic surgery.
For the intracerebroventricular (i.c.v.) serotonin injection, a
subset of animals received a 21 gauge cannula (15 mm length)
aimed at the left lateral ventricle [from bregma: anteroposterior
(AP) = −0.9 mm; mediolateral (ML) = +1.6 mm; dorsoventral
(DV) = −2.5 mm]. For the microdialysis study, a subset of
animal received a 20 gauge cannula (20 mm length) aimed at the
right ventromedial hypothalamus (from bregma: AP=−2.6 mm;
ML = −0.6 mm; DV = −7.8 mm). The cannulas were secured
to the skull with screws and dental cement. Immediately after
the surgery, a subcutaneous dose of penicillin (300,000 U.kg−1,
Bepeben R©) was administered. The rats were then placed in
individual cages with free access to water and food and continued
to receive the GbE treatment for the following 7 days. Food
intake and body weight were measured daily to check for the
post-surgical recovery.
Food Intake Measurement after
Intracerebroventricular Serotonin
After 3 days of the lateral ventricle cannulation, the animals were
fasted for 6 h and received an i.c.v. injection of 5.0 µL of vehicle
(artificial cerebrospinal fluid: 145 mM NaCl, 2.7 mM KCl; 1.0 mM
MgCl2; 1.2 mM CaCl2; 2.0 mM Na2HPO4; pH 7.4) or 5.0 µL
of vehicle containing 300 µg of 5-HT (H9523, Sigma-Aldrich,
United States). The injections were performed immediately
before lights out. After the injection, the animals were returned
to their individual cages and a known amount of chow was
offered. Food consumption was determined by weighting the
remaining chow after 12 and 24 h of the injection. Each animal
was injected twice, receiving vehicle or serotonin, on separate
days, with an interval of 2 days between the experiments. The
rats were randomly divided, so that half of the animals received
vehicle as first injection and the other half received serotonin as
first injection. The correct cannula positioning was evaluated by
the dipsogenic effect of 20 ng of angiotensin II (i.c.v.).
In Vivo Microdialysis
On the 13th day of the phytotherapy treatment, around 5 p.m.,
food was removed and the microdialysis probe was inserted
into the guide cannula. The probes were custom-constructed,
as previously described, with 2.0 mm of effective membrane
length and 13,000 Da cut-off (Mori et al., 1999; Pôrto et al.,
2009). The probe inlet was connected to a micro-infusion pump
(CMA-Harvard Apparatus, Kista, Stockholm, Sweden) and the
animals were connected to a swivel system (CMA Microdialysis R©)
allowing continuous perfusion with artificial cerebrospinal fluid.
Overnight infusion flow rate was 1.0 µL.min−1. In the next day,
around 8 a.m., flow rate was adjusted to 2.5 µL.min−1. After
allowing 60 min for stabilization, collection of 20-min dialysate
samples was started. Samples were collected into 10 µL of 0.5 M
perchloric acid and immediately injected into a high performance
liquid chromatography (HPLC) system (Mori et al., 1999; Telles
et al., 2003). All dialysate collections were performed between
9 and 12 a.m. Baseline samples were collected until 5-HT levels
were stable. Then, the Sham+GbE and the OVX+GbE animals
received 500 mg.kg−1 of GbE by gavage while the Sham and OVX
groups received 1.5 mL of vehicle. After the gavage procedure, six
additional 20-min. microdialysate samples were collected.
HPLC Analysis
Dialysate levels of 5-HT were measured by HPLC with
electrochemical detection. The system (ESA, Inc., Chelmsford,
United States) consisted of a pump with two PEEK pulse dampers
in series, a 50 µL Rheodyne PEEK sample loop, a 3 µM MD150
C18 reverse phase column, a model 5020 guard cell with 300 mV
potential, a model 5014A analytical cell set a −175 and 150 mV
in the first and second electrodes, respectively, and a model
5200A detector. The mobile phase consisted of 75 mM sodium
phosphate, 1.5 mM octanesulfonic acid, 50 µM EDTA, 150 µL
triethylamine.L−1, 20% acetonitrile, pH 3.0 at a flow rate of
0.6 mL.min−1 (Mori et al., 1999; Guimarães et al., 2002; Telles
et al., 2003).
Frontiers in Pharmacology | www.frontiersin.org 3 September 2017 | Volume 8 | Article 605
fphar-08-00605 September 4, 2017 Time: 17:6 # 4
Banin et al. GbE Improved Ovariectomy-Related Obesity
Histological Analysis and Weighing of
Visceral Adipose Tissue Depots
One day after the microdialysis experiment, the rats were
deeply anesthetized with thiopental (80 mg.kg−1; i.p.), the
abdominal cavity was opened and the retroperitoneal and
mesenteric fat pads were removed and weighed. The animals
were then perfused intracardially with PBS solution followed by
4% paraformaldehyde dissolved in PBS. Brains were removed
and kept in 4% paraformaldehyde for 1 week and then in 30%
sucrose solution for 4 days. The 45 µM sections were obtained
in a cryostat, stained with cresyl violet and examined under
an optical microscope for confirmation of the positioning of
the microdialysis membranes in the ventromedial hypothalamus
region. We considered only the results obtained in those
animals in which the microdialysis membrane was correctly
positioned.
Western Blotting Analysis
Additional rats were killed after an 8 h-fasting. The hypothalami
were removed and homogenized in 0.8 mL of solubilization
buffer (100 mM Tris, pH 7.5, 0.1 mg.mL−1 aprotinin,
2 mM phenylmethylsulfonyl fluoride, 10 mM sodium
orthovanadate, 100 mM sodium fluoride, 10 mM sodium
pyrophosphate, and 10 mM EDTA). Triton X-100 was added
to a final concentration of 10%. Samples were centrifuged
at 16,000 g for 40 min and 50 µg of protein were resolved
in SDS–polyacrylamide gel electrophoresis, transferred
to nitrocellulose membranes and incubated with primary
antibodies against the serotonergic receptors 5-HT1A (anti-5-
HT1A, ab79230), 5-HT1B (anti-5-HT1B, ab13896), and 5-HT2C
(anti-5-HT2C, ab133570), the serotonin transporter—5-HTT
(anti-5-HTT, ab172884), and the anorexigenic mediator pro-
opiomelanocortin (POMC; anti-POMC, ab180766). The blots
were incubated with peroxidase-conjugated secondary antibodies
and specific bands were detected by chemiluminescence (GE
Healthcare Bio-Sciences, Pittsburgh, PA, United States).
For evaluation of protein loading, all membranes were
stripped and re-blotted with anti-β-tubulin (Ab#2146)
primary antibody. Band intensities were quantified by optical
densitometry (Scion Image software, Scion Corporation,
Frederick, MD, United States). The measured density of all
proteins where then corrected to the density of β-tubulin levels.
The results are expressed as percentage of the intensity measured
in the Sham group. The whole pictures of Western blotting
analysis are provided in the Supplementary Data Sheet 1.
Statistical Analysis
Data are expressed as mean± SEM. The PASW Statistics version
21 software (SPSS Inc., United States) was adopted in all analysis
with the level of statistical significance set at p ≤ 0.05.
Comparisons of body mass and relative food intake within
Sham and OVX groups were performed by one-way ANOVA
with repeated measures. Comparisons of body mass, food intake,
body weight gain, and food efficiency between Sham and GbE
groups were carried out by Student’s t-test for independent
samples. Comparisons of body weight gain, relative food intake,
visceral adipose tissues depots, and uterus mass among all groups
were analyzed by two-way ANOVA followed by Tukey HSD test
adopting OVX and GbE as the fixed factors. The effect of acute
i.c.v. 5-HT on food intake in each group was assessed by the
paired Student’s t-test.
5-HT microdialysate levels are expressed as percentage of
the mean baseline level. For comparisons among the samples
collected throughout the experimental period in the same group,
one-way ANOVA followed by Tukey HSD test was performed.
The area under the curve (AUC) relating serotonin levels to
time after GbE or vehicle administration was calculated by the
trapezoidal rule. The comparisons of microdialysate 5-HT levels
among the four groups in each time point, serotonin AUC,
and Western blotting data were analyzed by two-way ANOVA
followed by Tukey HSD test considering OVX and GbE as main
factors. Detailed tables of statistical analysis are available in the
Supplementary Data Sheet 2.
RESULTS
Body Weight and Food Intake during the
8 Weeks after Ovariectomy
Both Sham [F(1,47) = 3928.55; p < 0.0001] and OVX
[F(1,48) = 7808.63; p < 0.0001] rats showed a progressive
elevation of their body masses, from week 0 (initial body mass)
to the end of week 8, as it can be observed in Figure 2A.
In comparison to the Sham group, the OVX rats presented
significantly higher body mass from the 2nd to the 8th week after
ovariectomy (week 2: 11%; week 3: 17%; weeks 4 and 5: 19%; week
6: 20%; week 7: 21%; and week 8: 22%, p < 0.0001). The total body
mass gain of the OVX group was 107% higher than that of the
Sham group (p < 0.0001), as it can be verified in Figure 2B.
Figure 2C shows that the Sham rats exhibited a significant
reduction of the relative food intake at the 4th (p = 0.015),
6th (p = 0.002), 7th (p = 0.001), and 8th weeks (p < 0.0001),
in relation to the 1st week of evaluation [F(1,10) = 1577.10;
p < 0.0001]. In the OVX group, the relative food intake decreased
significantly [F(1,8) = 4712.82; p < 0.0001] since the 2nd week
(week 2:−7%, p= 0.044; week 3:−17%, p= 0.001; week 4:−28%,
p < 0.0001; week 5:−29%, p < 0.0001; week 6:−34%, p < 0.0001;
week 7: −36%, p < 0.0001; and week 8: −34%, p < 0.0001).
In comparison to the Sham rats, the OVX group presented a
significantly higher food intake at the 1st (14%, p = 0.006) and
2nd weeks (9%, p = 0.022). However, this group presented a
significant reduction in food intake in the 7th week in relation to
Sham group (−10%, p= 0.009). By the end of the 8th week, food
intake was similar between the groups. In addition, Figure 2D
shows that the OVX group presented a 160% increase of food
efficiency (p < 0.0001) in comparison to the Sham group.
Body and Adipose Tissue Mass and
Food Intake in Response to 14 Days of
GbE Treatment
Body mass gain during the 14 days of GbE treatment failed to
show significant differences among the groups [F(3,51) = 0.506,
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FIGURE 2 | Body mass and food intake during the 8 weeks after ovariectomy or false-ovariectomy. (A) Body mass; (B) body mass gain (% of initial body mass); (C)
relative food intake (g.100 g−1bw.24 h−1); and (D) food efficiency (g.kcal−1) of Sham (n = 48) and OVX rats (n = 49). ∞p ≤ 0.05 vs. week 0 within the Sham group;
δp ≤ 0.05 vs. week 0 within the OVX group; ∗p ≤ 0.05 vs. Sham.
p = 0.680, Figure 3A]. Ovariectomy increased the mass of
the retroperitoneal [F(3,79) = 45.66, p < 0.0001] and the
mesenteric [F(3,79) = 49.44, p < 0.0001] fat depots and of the
sum of these visceral fat depots [F(3,79) = 54.96, p < 0.0001],
in comparison to Sham and the Sham + GbE groups. GbE
attenuated these adiposity measures, as the OVX + GbE rats
showed a 23% reduction (p = 0.027) of retroperitoneal fat pad
mass [F(3,79) = 7.47, p= 0.008] and a 20% reduction (p= 0.035)
of visceral fat pads sum [F(3,79) = 54.96, p < 0.0001], in relation
to the OVX rats (Figure 3B).
The cumulative food intake [F(3,22) = 12.30, p = 0.003] was
lower in OVX + GbE than in Sham (−15%, p = 0.019) and
Sham+GbE (−14%, p= 0.023) groups (Figure 3C). As expected,
the lack of ovarian hormones promoted a significant atrophy of
the uteri [F(3,95) = 584.46; p < 0.0001], as compared to both
Sham and Sham+ GbE groups (Figure 3D).
Food Intake in Response to
Intracerebroventricular Serotonin
Serotonin infusion significantly reduced food intake in relation
to vehicle infusion in the Sham (−42%, p = 0.0017 and −25%,
p = 0.0010; Figure 4A) and Sham + GbE (−14%, p = 0.024
and −15%, p = 0.040; Figure 4B) groups. Serotonin-induced
hypophagia was abolished in the OVX group (Figure 4C) and
was restored by the GbE treatment (−39%, p= 0.047 and−42%,
p= 0.037; Figure 4D).
Effect of GbE on Serotonin Levels in
Microdialysates of the Medial
Hypothalamus
Basal extracellular levels of serotonin were similar
among Sham (1.05 ± 0.22 pg.50 µL−1, n = 6–7),
Sham + GbE (1.84 ± 0.35 pg.50 µL−1, n = 5–6), OVX
(1.40 ± 0.38 pg.50 µL−1, n = 5–10) and OVX + GbE
(1.11 ± 0.20 pg.50 µL−1, n = 7–10); [F(3,30) = 1.172, p = 0.339]
groups.
The gavage with vehicle failed to significantly affect 5-HT
extracellular levels in both the Sham [F(8,58) = 2.427, p = 0.072]
and the OVX groups [F(8,68) = 0.7189, p = 0.674]. The injection
of GbE failed to significantly alter 5-HT microdialysate levels
in the Sham + GbE group [F(8,52) = 0.7869, p = 0.617].
On the other hand, it caused a significant elevation of 5-HT
levels in the OVX + GbE group [F(8,77) = 2.675, p = 0.013].
The levels were significantly elevated from baseline at the
sample collected 60–80 min after the acute dose of GbE
(Figure 5A).
The comparison among the groups at each time point
showed that GbE promoted a significant increment of 5-HT
levels [F(3,29) = 9.255, p = 0.005] in both Sham + GbE and
OVX+GbE rats, in the 20–40 min sample (67%, p= 0.042; 64%,
p = 0.033, respectively) in comparison to the OVX group. GbE
also increased 5-HT level of the OVX+ GbE group in relation to
Frontiers in Pharmacology | www.frontiersin.org 5 September 2017 | Volume 8 | Article 605
fphar-08-00605 September 4, 2017 Time: 17:6 # 6
Banin et al. GbE Improved Ovariectomy-Related Obesity
FIGURE 3 | Body mass gain and cumulative food intake during the 14 days of GbE therapy, and final fat depots and uterus mass. (A) Body mass gain (% of initial
body mass) of Sham (n = 13), Sham + GbE (n = 12), OVX (n = 14), and OVX + GbE (n = 11) groups; (B) visceral adipose tissue depots mass (g.100 g−1) of Sham
(n = 21–24), Sham + GbE (n = 21–23), OVX (n = 18–25), and OVX + GbE (n = 18–23) groups; (C) cumulative food intake (g.100 g−1bw.24 h−1) of Sham (n = 13),
Sham + GbE (n = 12), OVX (n = 14), and OVX + GbE (n = 11) groups; (D) uterus mass (g) Sham (n = 21–24), Sham + GbE (n = 21–23), OVX (n = 18–25), and
OVX + GbE (n = 18–23) groups. ∗p ≤ 0.05 vs. Sham; #p ≤ 0.05 vs. Sham + GbE; &p ≤ 0.05 vs. OVX.
that of the Sham group at the 80–100 min sample [67%, p= 0.029;
F(3,27) = 5.292, p= 0.031; Figure 5A].
The AUC relating serotonin levels to time after GbE
administration was higher in OVX+GbE group [F(3,31) = 6.425,
p = 0.017] in comparison to the Sham (47%, p = 0.046) and the
OVX group (45%, p= 0.040) (Figure 5B).
Effects of Ovariectomy and GbE on
Hypothalamic Protein Expression
No differences were observed among the groups in protein levels
of 5-HT1A [F(3,48) = 0.928, p = 0.435], 5-HT1B [F(3,49) = 0.589,
p = 0.625], 5-HT2C [F(3,49) = 0.865, p = 0.465], and POMC
[F(3,45) = 0.371, p = 0.774] (Figures 6A–D). However, there was
a significant 60% reduction (p= 0.043) in the protein levels of the
5-HTT (Figure 6E) [F(3,45) = 3.321, p = 0.029] of OVX + GbE
rats in relation to that of the Sham group. Additionally, that
group also showed a trend to elevated levels in relation to the
Sham+ GbE (p= 0.054) and OVX (p= 0.075) groups.
DISCUSSION
It is well recognized that menopause is associated with excess
body mass gain and visceral fat deposition (MacLean et al., 2010;
Asarian and Geary, 2013; Dalal and Agarwal, 2015). In the present
study, ovariectomy induced increased body mass since the 2nd
week, leading to a twofold total increase by the 8th week. By this
time, visceral adipose depots were augmented, a condition known
to be linked with the development of chronic diseases such as
insulin resistance, diabetes, cardiovascular disorders, and cancer
(Stachowiak et al., 2015).
The daily food intake of the OVX rats showed a transient
increase, in the 1st and 2nd weeks, but was normalized by the
8th week. This pattern of feeding agrees with a previous report
in OVX rats (Ferreira et al., 2012) and may be attributed to
a compensatory mechanism to control energy balance after a
period of hyperphagia (Woods, 2013). However, it is important
to emphasize that, although both the Sham and the OVX rats
exhibited a progressive decrease of food intake over the 8
weeks, the decrement was more pronounced in the OVX group,
showing that the excess weight gain did not rely on excess energy
consumption. This can be explained, at least in part, by the
increased food efficiency shown by the OVX rats, in accordance
with a previous report on the consequences of the absence of
ovarian hormones (MacLean et al., 2010).
Estrogen replacement has been shown to attenuate obesity in
both OVX animals (Yu et al., 2011; Ibrahim et al., 2015) and
in post-menopausal women (Butera, 2010). Estrogens regulate
food intake by reducing the activity of orexigenic factors, such
as ghrelin and neuropeptide Y (NPY), as well as by stimulating
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FIGURE 4 | Food intake in response to intracerebroventricular serotonin. Relative food intake of (A) Sham (n = 4), (B) Sham + GbE (n = 4), (C) OVX (n = 4), and
(D) OVX + GbE (n = 5) in the 12 and 24 h periods after the intracerebroventricular injection of either vehicle or 300 mg 5-HT. ∗p ≤ 0.05 vs. vehicle.
anorexigenic signals, such as cholecystokinin, brain-derived
neurotrophic factor and the serotonin pathway (Bethea et al.,
2002, 2016; Butera, 2010; Zhu et al., 2013; Grochans et al., 2014).
Hormone replacement therapy (HRT) remains the most used
treatment for ameliorating menopause-related symptoms, as it
presents positive effects on food intake control and body weight
gain. Nevertheless, as HRT may lead to important side effects
such as breast cancer, heart stroke, and thrombosis, this therapy
must be well evaluated and constantly monitored (Pines and
Shapiro, 2015). In this context, the development of alternative
treatments for menopause management is highly desirable.
Previous studies from our laboratory have demonstrated that
GbE was efficient in reducing food intake, body weight gain,
and visceral adiposity in diet-induced obese male rats (Banin
et al., 2014; Hirata et al., 2015). Due to this positive effect of
GbE on energy homeostasis, the present study was aimed at
evaluating if this herbal medicine would attenuate the effects
of ovarian hormones absence on energy homeostasis and, if
so, whether the hypothalamic serotonin system played a role.
The results showed that GbE did reduce spontaneous feeding
and attenuated body adiposity of OVX rats during the 2-week
treatment. Although few studies have addressed the mechanisms
involved in GbE-induced hypophagia, a positive effect of GbE
on components of serotonergic signaling pathway has been
documented (Huguet et al., 1994; Bolaños-Jiménez et al., 1995;
Sloley et al., 2000).
Since exogenous 5-HT and agents that enhance synaptic
availability of endogenous 5-HT are known to suppress feeding
(Leibowitz and Alexander, 1998), in the present work food
intake was assessed after an i.c.v. injection of 5-HT. The results
demonstrated that OVX rats failed to show hypophagia in
response to an acute central infusion of serotonin. This finding
agrees with the demonstration of impairment of fenfluramine-
induced hypophagia in OVX rats in comparison to estradiol-
replaced OVX animals (Rivera and Eckel, 2005). It has been
previously reported that fluoxetine decreased appetite and body
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FIGURE 5 | Medial hypothalamic serotonin extracellular levels as measured by
in vivo microdialysis. (A) 5-HT levels (% baseline) in 20-min VMH
microdialysate samples collected before (baseline –40 to 0 min) and up to
120 min after gavage with either vehicle or 500 mg.kg−1 of GbE and (B) area
under the curve (AUC) of 5-HT extracellular levels during the 120 min of
microdialysate collection after gavage of Sham (n = 6–7), Sham + GbE
(n = 5–6), OVX (n = 5–10), and OVX + GbE (n = 7–10). ∗p ≤ 0.05 vs.
baseline; § p ≤ 0.05 vs. Sham; #p ≤ 0.05 vs. Sham + GbE; &p < 0.05 vs.
OVX; δp ≤ 0.05 vs. OVX + GbE.
mass index of post-menopausal women after 2–3 months of
treatment but these effects were no longer observed after 6
months of therapy (Chojnacki et al., 2015).
Importantly, GbE improved serotonin effectiveness in the
OVX animals, as seen by the restored feeding response to the
neurotransmitter in the OVX + GbE group. Along with the
observation of the low food intake presented by OVX + GbE
rats during the 14-day treatment, this finding allows the
suggestion that GbE-induced hypophagia relied, at least in part,
on serotonergic mechanisms.
Indeed, the microdialysis experiments evidenced a potent
effect of GbE on the serotonergic system of the OVX rats, as
the treatment significantly stimulated 5-HT microdialysate levels.
This agrees with the demonstration that GbE 761 increased 5-HT
uptake by mice cortical synaptosomes, an effect attributed to the
flavonoid compounds of GbE (Ramassamy et al., 1992). On the
other hand, it contrasts with the observation of a previous report
in which the authors did not observe any effect of GbE on the
pre-frontal cortex extracellular 5-HT levels of rats (Yoshitake
et al., 2010).
Serotonin hypophagia has been attributed to its interaction
with receptors 5-HT1A, 5-HT1B, and 5-HT2C (Huang et al., 2004).
Pretreatment with 5-HT1A antagonists impaired the hypophagia
induced by fluoxetine administration in the pre-limbic cortex of
fasted rats (Stanquini et al., 2015). Acting on 5-HT2C receptors,
5-HT has been shown to induce the cleavage of POMC into the
active anorexigenic factor α-melanocyte-stimulating hormone
(α-MSH). Acting on 5-HT1B, serotonin reportedly inhibited the
orexigenic mediators NPY and agouti-related protein (AgRP) and
activated the anorexigenic peptides α-MSH and cocaine- and
amphetamine-regulated transcript (CART) (Pratt et al., 2016).
Inhibition of the 5-HTT decreased food intake and body weight
in rats and humans (Huang et al., 2004; Olivier and van Oorschot,
2005).
Available data addressing effects of GbE in the modulation
of serotonergic receptors involved in energy homeostasis are
very scarce. In the rat brain, GbE has been shown to prevent
the stress-induced 5-HT1A desensitization in the hippocampus
and to reverse the aging-induced decrement of cortical 5-HT1A
density (Huguet et al., 1994; Bolaños-Jiménez et al., 1995).
A neuroprotective ability of GbE has been proposed based both
on the ability of the phytoestrogen kaempferol, isolated from
GbE leaves, to reduce MAO-A/B activity in rat brain cells in
culture, and on its antioxidant effect in a lipid-peroxidation
assay (Sloley et al., 2000). A better understanding of the central
targets of GbE is relevant for the proposal of beneficial effects
of this herbal medicine on body weight gain, particularly after
menopause.
In the present study, GbE failed to affect hypothalamic levels
of 5-HT1A, 5-HT1B, 5-HT2C, and POMC. On the other hand,
it induced a 60% significant decrement of hypothalamic 5-HTT
density, only in the OVX rats. It is, thus, possible to suggest
that GbE increased serotonin effectiveness through reuptake
inhibition, what was probably relevant for the reduction of food
intake and stimulation of 5-HT microdialysate levels induced
by GbE. Differently from its action on the OVX rats, GbE had
no effect on the hypothalamic 5-HTT levels in the Sham-OVX
group, a finding consistent with its lack of effect on feeding and
microdialysate serotonin levels in this group.
As mentioned above, estrogens’ effects on the serotonergic
system are complex. Although the majority of the studies
have pointed to an overall stimulatory effect of estrogens,
inhibitory consequences have also been described (Barth et al.,
2015). Low estrogen levels have been associated with reduced
5-HT concentration in some brain areas, such as cortex
and striatum (Hao et al., 2011). Furthermore, OVX rats
reportedly presented a marked reduction in the number of
serotonin-positive neurons in the dorsal raphe nuclei. This
reduction was reversed by either estrogen or remifemin, a
herbal medicine containing triterpene glycosides and phenolic
substances, used for the relief of menopausal symptoms (Wang
et al., 2016).
The present results also indicated a stimulatory action, as
evidenced by the absence of serotonin hypophagia and the
slightly decreased microdialysate levels in the OVX group.
A recent study in mice has shown an inverse relationship between
estrogen and serotonergic activity, as 5-HT striatal microdialysate
levels were found to be lower in the high estrogen than in the
low estrogen phase of the ovarian cycle. Importantly, this effect
was linked to inhibition of 5-HTT expression (Yang et al., 2015),
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FIGURE 6 | Western blotting analysis of the hypothalamic expression of the proteins serotonin receptors 1A, 1B, and 2C, serotonin transporter (5-HTT), and POMC.
(A) 5-HT1A; (B) 5-HT1B; (C) 5-HT2C; (D) POMC; and (E) 5-HTT expression, in % of Sham group expression. Sham (n = 12–13), Sham + GbE (n = 11–12), OVX
(n = 12–14), and OVX + GbE (n = 10–11). ∗p < 0.05 vs. Sham.
similarly to the present observation concerning the effect of
GbE in the OVX rats. These considerations raise the suggestion
that the positive role of GbE on serotonergic regulation may
rely on mechanisms similar to those targeted by estrogens. This
agrees with the absence of GbE’s effects on the Sham-OVX
animals.
In human breast cancer cells, both estrogenic and
antiestrogenic actions of GbE have been demonstrated, in
a biphasic manner dependent on both estrogen and GbE
concentrations. The antiestrogenic role of GbE has been linked
to competition with estrogens for ER-β binding, pointing GbE
as a chemopreventive agent for breast cancer development, an
important side effect of HRT (Oh and Chung, 2004, 2006).
In summary, ovariectomy increased body mass and adiposity
and impaired the anorexigenic effect of serotonin. On the
other hand, GbE reduced food intake and body adiposity,
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restored serotonin effectiveness, enhanced 5-HT levels of
medial hypothalamus microdialysates and decreased 5-HTT
hypothalamic levels. Our results suggest that GbE is a potential
alternative therapy for the management of weight gain associated
with menopause. More studies are necessary to understand the
mechanisms involved in the beneficial role of G. biloba on the
hypothalamic serotonin pathway.
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